Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study
about
Prediction of vascular risk after stroke - protocol and pilot data of the Prospective Cohort with Incident Stroke (PROSCIS).Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation.Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis.Assessing the Incremental Role of Novel and Emerging Risk Factors.Peripheral arterial tonometry for risk stratification in men with coronary artery diseaseLipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosisAssociation of Lp-PLA2 Mass and Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients.Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional studyClinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.Higher Levels of Lipoprotein Associated Phospholipase A2 is associated with Increased Prevalence of Cognitive Impairment: the APAC StudyGuidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Molecular mechanisms underlying application of serum procalcitonin and stool miR-637 in prognosis of acute ischemic stroke.The risk of stroke in postmenopausal women receiving hormonal therapy.Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke.Evidence for using alpha-lipoic acid in reducing lipoprotein and inflammatory related atherosclerotic risk.Cardiovascular Disease Risk Assessment: Review of Established and Newer Modalities.Partial likelihood ratio tests for the Cox model under complex sampling.Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study
P2860
Q30559655-CBB83BC3-A2AC-4DCC-9DC3-EBEEB79C7F9EQ30681951-C71193F9-CBA8-4C0E-A8E2-702A5D4830C6Q33514587-6E2212F5-DA47-42A2-B4F1-7D0A13D7745AQ33995565-29B6AD50-2449-48C1-8B77-5F5718148B77Q34038387-51664C41-0F23-4CC7-8BDC-2614A99B0A47Q34890672-E190BD3D-534E-4296-8E41-E2D9F52F178AQ35556624-42A8FEDD-FB1E-473C-ADD0-F9CFB6D9B4D2Q35670588-61E226C2-D39A-4716-B789-0FD90858F6D8Q36707842-A5D627F4-AB28-4251-844F-865136732340Q36833592-3D2E94A5-5658-4E31-AE62-90BDC52E6636Q37243907-8840E2E2-D7AD-4304-83BA-E27E53E5B7BDQ37251490-C9DC1EAE-46DD-4F0B-B18B-85594EB91B19Q37393419-F79CA3CD-E09C-4C1F-BB01-2BE9B54BB923Q37610401-337BD1E0-6976-42DB-B873-F81E00C3A888Q37707415-C5E6C057-4670-4766-996B-245FFF2130A0Q37838426-9E925156-2048-431D-A0A1-116060A6F121Q38011272-EC718BBE-4295-487D-BF27-95A57D91137BQ38608589-C6D29494-9B8F-41F1-AD93-9E5E873169C9Q46182888-B67DCC58-65E5-487B-96F5-869892878DFCQ58792031-53E3AA3E-FDF5-40E3-A0DD-632206E90A1C
P2860
Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipoprotein-associated phospho ...... sk in Communities (ARIC) study
@en
Lipoprotein-associated phospho ...... osclerosis Risk in Communities
@nl
type
label
Lipoprotein-associated phospho ...... sk in Communities (ARIC) study
@en
Lipoprotein-associated phospho ...... osclerosis Risk in Communities
@nl
prefLabel
Lipoprotein-associated phospho ...... sk in Communities (ARIC) study
@en
Lipoprotein-associated phospho ...... osclerosis Risk in Communities
@nl
P2093
P2860
P50
P1433
P1476
Lipoprotein-associated phospho ...... sk in Communities (ARIC) study
@en
P2093
Aaron R Folsom
Christie M Ballantyne
Heejung Bang
Lloyd Chambless
Richey Sharrett
Ron C Hoogeveen
Vijay Nambi
P2860
P304
P356
10.1161/STROKEAHA.107.513259
P407
P577
2008-12-18T00:00:00Z